ArticleScience advances2021
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds.
Haiyan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papertrialcites it